<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04709510</url>
  </required_header>
  <id_info>
    <org_study_id>RetroThrombo</org_study_id>
    <nct_id>NCT04709510</nct_id>
  </id_info>
  <brief_title>Short-term Perioperative Thromboprophylaxis After Major Abdominal Surgery</brief_title>
  <official_title>Outcomes of Short-term Perioperative Thromboprophylaxis After Gastrointestinal Cancer Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istanbul Medeniyet University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istanbul Medeniyet University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Major abdominal surgery for cancer is major risk factor for thromboembolism. Patients who&#xD;
      undergo major abdominal surgery are prone to develop venous thromboembolism, both in the&#xD;
      early postoperative period and after hospital discharger. There are strong recommendations in&#xD;
      the international guidelines in favor to pharmacological thromboprophylaxis. Thus there is no&#xD;
      consensus dor the duration of the prophylaxis. There are authors that suggest extended&#xD;
      prophylaxis up to 4 week after surgery. On the other hand, there are prospective randomized&#xD;
      trials that inpatient (short-term up to 7-10 days) prophylaxis is adequate.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a retrospective cohort study with 89 patients who underwent major abdominal surgery&#xD;
      for colorectal and gastric cancer. All patients received short term prophylaxis (during&#xD;
      hospital stay only) rather than extended prophylaxis (4 weeks). All participants received&#xD;
      duplex ultrasound in the study period for the diagnosis of deep vein thrombosis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Actual">August 31, 2020</completion_date>
  <primary_completion_date type="Actual">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Retrospective Cohort</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The incidence of thromboembolic events by radiological assessment</measure>
    <time_frame>3 years follow up</time_frame>
    <description>All patients in the cohort received short time prophylaxis for deep vein thrombosis instead of prolonged duration. All patients will be assessed with ultrasound.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of predisposing factors of the patients</measure>
    <time_frame>3 years follow up</time_frame>
    <description>The patients with deep vein thrombosis in the cohort will be assessed according to their postoperative period features, histories, chemo treatments etc. with and questionnaire.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">89</enrollment>
  <condition>Deep Vein Thrombosis</condition>
  <arm_group>
    <arm_group_label>AllPatients</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>There is only one cohort in this study. They all received the same follow up and ultrasound protocol.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Duplex Ultrasound</intervention_name>
    <description>Duplex Ultrasound was performed for every participants for the diagnosis of symptomatic or asymptomatic deep vein thrombosis</description>
    <arm_group_label>AllPatients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Older than 18&#xD;
&#xD;
          -  Major abdominal surgery gor colorectal or gastric cancer&#xD;
&#xD;
          -  Caprini Risk score less than 9&#xD;
&#xD;
          -  No history of anticoagulant treatment&#xD;
&#xD;
          -  Thromboprophylaxis during hospital stay only&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Younger than 18&#xD;
&#xD;
          -  Caprini Risk score 9 and above&#xD;
&#xD;
          -  History of anticogulants&#xD;
&#xD;
          -  Not reachable by phone etc&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Orhan Alimoglu, Prof</last_name>
    <role>Study Chair</role>
    <affiliation>Istanbul Medeniyet University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Istanbul Medeniyet University</name>
      <address>
        <city>Istanbul</city>
        <state>Kadikoy</state>
        <zip>34722</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 8, 2021</study_first_submitted>
  <study_first_submitted_qc>January 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 14, 2021</study_first_posted>
  <last_update_submitted>January 13, 2021</last_update_submitted>
  <last_update_submitted_qc>January 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istanbul Medeniyet University</investigator_affiliation>
    <investigator_full_name>Nuray COLAPKULU</investigator_full_name>
    <investigator_title>Surgical Resident (Research Assistant) at General Surgery</investigator_title>
  </responsible_party>
  <keyword>deep vein thrombosis</keyword>
  <keyword>short-term thromboprophylaxis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thrombosis</mesh_term>
    <mesh_term>Venous Thrombosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

